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Development and Evaluation of a Novel, Semiautomated Clostridium
difficile Typing Platform
Lars F. Westblade,a Robin R. Chamberland,a Duncan MacCannell,d Rachel Collins,a Erik R. Dubberke,b W. Michael Dunne, Jr.,a*
Carey-Ann D. Burnhama,c
Departments of Pathology and Immunology,a Medicine,b and Pediatrics,c Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA; Division of
Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USAd
We describe a novel, semiautomated Clostridium difficile typing platform that is based on PCR-ribotyping in conjunction with a
semiautomated molecular typing system. The platform is reproducible with minimal intra- or interassay variability. This
method exhibited a discriminatory index of 0.954 and is therefore comparable to more arduous typing systems, such as pulsed-
field gel electrophoresis.
Clostridium difficile, the etiological agent of C. difficile infection(CDI), is an important cause of both hospital- and commu-
nity-acquired infectious diarrhea (1, 2). The emergence of hyper-
virulentC. difficile isolates and in particular the NAP1/BI/027 iso-
late has altered the epidemiology of C. difficile infections in many
health care institutions, resulting in increased severity and dura-
tion of disease, with concomitant increases to the length and cost
of hospitalization (1). Therefore, typing methods that can dis-
criminate NAP1/BI/027 and other emerging hypervirulent C. dif-
ficile isolates may be important for understanding the transmis-
sion dynamics of the organism. In addition, it has recently been
demonstrated that the analytical sensitivity and specificity of C.
difficile diagnostic assays may be dependent on the C. difficile
strain type (3). In addition, recent reports suggest that the relapse
rate following treatment with certain novel antianaerobic and C.
difficile-specific antimicrobials could correlate with C. difficile
strain type (4, 5); thus, an appreciation of the isolate typemay play
a role in patient management in the future. As such, C. difficile
typingmay have the potential to improve themanagement of CDI
beyond clinical surveillance, especially in the hospital setting, and
it may be important for clinical laboratorians and infection con-
trol specialists to have a baseline understanding of the different C.
difficile isolates circulating in their institutions.
Pulsed-field gel electrophoresis (PFGE) is the principal refer-
ence method employed for C. difficile typing in North America
(6). While PFGE affords acceptable discriminatory power (6), it
does suffer from some important limitations, in particular the
labor intensity, technical expertise, turnaround time, and neces-
sity for control strains to be processed alongside isolates of epide-
miological interest. In Europe, the predominant method for C.
difficile typing is PCR-ribotyping, which involves the PCR ampli-
fication of the intergenic space region between the 16S and 23S
rRNA genes (7, 8, 9). Formany years, epidemiologic studies forC.
difficile have relied on PFGE and PCR-ribotyping to determine
strain relatedness; multiple-locus variable-number tandem-re-
peat analysis (MLVA) forC. difficile typing has also been described
for recent studies (6, 10, 11, 12). Although this method does ap-
pear to be reproducible and discriminatory, it requires access to a
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FIG 1 Intra- and interassay variability of the PCR-ribotyping/DiversiLab C.
difficile typing platform. Dendrogram illustrating the gel electrophoresis pro-
files of 24 PCR-ribotyping reactions obtained for eight different C. difficile
isolates (isolates A to H). Samples loaded onto the first Agilent chip are indi-
cated by lightface capitalized letters, while PCR-ribotyping reactions loaded
onto the secondAgilent chip are indicated by letters in bold italics. The percent
SI is indicated by the bar below the dendrogram; isolates with a SI of95% are
considered very related or identical.
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genetic analyzer/DNA sequencer, which is cost prohibitive to
many laboratories.
The objective of this study was to develop and validate a semi-
automated PCR-ribotyping platform that would further reduce
labor intensity, allow analysis of isolates in real time, provide ob-
jective downstream data analysis, maintain discriminatory power,
and be a feasible option for routine benchtop typing of C. difficile
isolates in a clinical setting. As such, we evaluated the performance
of PCR-ribotyping in conjunction with the DiversiLab system
(bioMérieux, Durham, NC) and the 2100 Bioanalyzer instrument
(Agilent; Santa Clara, CA, USA) for fragment separation and
PCR-ribotype band pattern analysis. A significant advantage of
this platform is that all resultant banding patterns are banked
electronically so that they may be recalled and compared retro-
spectively.
(This work was presented in part at the 111th General Meeting
of the American Society for Microbiology, New Orleans, LA, May
2011.)
Initially, we evaluated the intra- and interassay variability of
the PCR-ribotyping/DiversiLab platform. Therefore, in a blinded
experiment, prior to PCR-ribotype amplification, genomic DNA
isolated from eight C. difficile isolates (labeled A to H) previously
characterized as having unique PFGE types (6) was distributed
into 24 tubes such that each tube contained DNA from only one
isolate (C. difficileDNAwas isolated using the BiOStic bacteremia
DNAkit [MOBIO; Carlsbad, CA]). To perform the PCR-ribotyp-
ing reaction, a 25-l PCR mixture that included 100 ng of C.
difficile DNA, a Ready-To-Go randomly amplified polymorphic
DNA (RAPD) analysis bead (GE Healthcare Life Sciences; Piscat-
away, NJ), and primers complementary to the 3= end of the 16S
rRNA gene (5=-CTGGGGTGAAGTCGTAACAAGG-3=) and the
5= end of the 23S ribosomal gene (5=-GCGCCCTTTGTAGCTTG
ACC-3=) at a final concentration of 0.5 M was assembled (13).
The amplification conditions were 35 cycles of denaturation at
94°C for 1min, annealing at 55°C for 1min, and extension at 72°C
for 1 min. The PCR products were loaded into two different
DiversiLab DNA chips (bioMérieux; Durham, NC) according to
themanufacturer’s specifications and resolved using the 2100Bio-
analyzer instrument. The resultant banding patterns were ana-
lyzed using the DiversiLab Bacterial Barcodes software program,
which uses curve-based Pearson coefficients for pairwise similar-
ity scores (14). The data were organized into a dendrogram, and a
similarity index (SI) for each pair was calculated (Fig. 1). By ap-
plying a SI of95%, the PCR-ribotype band patterns were sepa-
rated into eight clusters, with each cluster corresponding to an
isolate. Upon examination of the resultant dendrograms, it is clear
that independent PCR-ribotype patterns obtained for each C. dif-
ficile isolate cluster together when loaded onto either the same or
different DNA chips and that this is both discriminatory and re-
producible. Taken together, these data support our assessment of
limited intra- and interassay variability.
To assess the effect of culture duration and subculture fre-
FIG 2 Evaluation of the performance of the PCR-ribotyping/DiversiLab C.
difficile typing platform at the local level. The dendrogram illustrates the elec-
trophoresis profiles of a collection of 74C. difficile isolates obtained from both
the CDC and our institution. Isolates obtained from the CDC are indicated by
their PFGEpulsotype and are in bold italics, while patient isolates are indicated
numerically. The collection was differentiated into 17 clusters with 15 unre-
lated strains, yielding a discrimination index of 0.954. The percent SI is indi-
cated by the bar below the dendrogram;95% are very related or identical.
Westblade et al.
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quency on the reproducibility of the PCR-ribotype band patterns,
a C. difficile isolate (ATCC 9689) was incubated anaerobically at
35°C on cycloserine-cefoxitin-fructose agar (CCFA) plates for 2, 5
or 14 days or consecutively passaged onto CCFA plates one, three
or five times. Subsequently, the cells were collected, their DNA
was extracted, and PCR-ribotyping was performed. The PCR-ri-
botype band patternswere analyzed using theDiversiLabBacterial
Barcodes software program, and dendrograms to illustrate strain
relatedness were generated. From inspection of the PCR product
electrophoresis profiles and the associated dendrograms, it was
found that PCR-ribotype patterns are not altered significantly in
response to either culture duration (SI  98% across all condi-
tions) or subculture frequency (SI  99% across all conditions),
indicating that the semiautomated typing platform can tolerate
considerable variation in culture conditions; this has been dem-
onstrated previously for other typing methods (15, 16).
In an effort to evaluate the performance of the semiautomated,
PCR-ribotyping platform at typing C. difficile isolates at the local
level, a collection of 50 C. difficile isolates cultured from the stools
of patientswith a positive toxinA/B assay in our institution and, as
a calibrant, 24C. difficile isolates whose PFGEpulsotypes had been
previously determined (6) was analyzed (Fig. 2). To ensure a
highly diverse calibrant collection, C. difficile isolates with the
NAP1, NAP2, NAP4, NAP6, and NAP12 PFGE pulsotypes and
isolates that did not map to previously characterized PFGE pulso-
types (UN for “unnamed” types) were included. The 74 isolates
were separated into 17 clusters, with 15 unrelated isolates yielding
a discrimination index (D) (17) of 0.954 with 95% confidence
intervals forD of 0.931 to 0.977 (18), which is in very close agree-
ment with findings of previous studies evaluating the discrimina-
tory power of differentC. difficile typingmethods (6, 9). However,
the discriminatory index of some of these prior studies could be
somewhat skewed, since NAP1 strains are typically in abundance
in contemporary epidemiological studies.
A requirement of molecular typing methods is an ability to
group related isolates and differentiate unrelated isolates. Our
method can do both, grouping the PCR-ribotyping patterns ob-
tained for isolates with identical PFGE pulsotypes and differenti-
ating the PCR-ribotyping patterns attained for isolates with dif-
ferent PFGE pulsotypes. In an effort to further validate the
discriminatory power of the semiautomated, PCR-ribotyping
platform, a collection of patient isolates whose PCR-ribotyping
patterns clustered with those obtained for isolates with known
PFGE pulsotypes (i.e., calibrant isolates) was analyzed using
PFGE. In all cases, the patient isolate yielded a PFGE pulsotype
very similar, if not identical, to that of the calibrant isolate it had
clustered with after PCR-ribotyping analysis (Table 1).
The novel, semiautomated C. difficile typing platform de-
scribed here has some advantages over PFGE and other more in-
tensive molecular typing methodologies; in particular, it is less
labor-intensive. Data analysis is automated, easy to perform, and
can be done within a matter of minutes, while ensuring a high
discriminatory power. In addition, the ability to bank isolate PCR-
ribotype patterns for retrospective and prospective analysis is an
advancement in C. difficile typing and could facilitate the rapid,
streamlined examination of epidemiological trends.
At present, the primary utility of C. difficile typing is to assist
epidemiological studies; however, it is possible that real-time C.
difficile typing will become increasingly relevant in routine clinical
management to identify the predominant C. difficile isolates in an
institution prior to administration of expensiveC. difficile-specific
antimicrobials and to monitor diagnostic assay performance. Af-
terC. difficile is recovered in culture, the hands-on time per isolate
to complete this typing method is approximately 1 h. After the
initial investment of acquiring the hardware and software for this
method, the cost of analyzing a single isolate is approximately $50.
However, up to 12 samples can be analyzed in a single chip or run,
and if 12 isolates are run in a batch, the cost per isolate is reduced
to approximately $35. With the ability to bank banding patterns
and compare isolates in real-time to previously typed isolates, it
will be relatively easy for institutions to create their ownC. difficile
strain typing database.
Therefore, we believe that the rapid, facile, and discriminatory
novel, semiautomated PCR-ribotyping platform described herein
will be favorably useful to epidemiologists, clinicians, and labora-
tory medicine professionals involved in managing CDIs.
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